| 000 | 01676 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515103759.0 | ||
| 264 | 0 | _c20080317 | |
| 008 | 200803s 0 0 eng d | ||
| 022 | _a1524-4636 | ||
| 024 | 7 |
_a10.1161/ATVBAHA.107.159442 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarx, Isabelle | |
| 245 | 0 | 0 |
_aCorrection of bleeding symptoms in von Willebrand factor-deficient mice by liver-expressed von Willebrand factor mutants. _h[electronic resource] |
| 260 |
_bArteriosclerosis, thrombosis, and vascular biology _cMar 2008 |
||
| 300 |
_a419-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBleeding Time |
| 650 | 0 | 4 | _aBlood Coagulation Tests |
| 650 | 0 | 4 |
_aDNA, Complementary _xanalysis |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aGene Transfer Techniques |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Mutant Strains |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_avon Willebrand Diseases _xgenetics |
| 650 | 0 | 4 |
_avon Willebrand Factor _xgenetics |
| 700 | 1 | _aLenting, Peter J | |
| 700 | 1 | _aAdler, Thure | |
| 700 | 1 | _aPendu, Ronan | |
| 700 | 1 | _aChristophe, Olivier D | |
| 700 | 1 | _aDenis, Cécile V | |
| 773 | 0 |
_tArteriosclerosis, thrombosis, and vascular biology _gvol. 28 _gno. 3 _gp. 419-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/ATVBAHA.107.159442 _zAvailable from publisher's website |
| 999 |
_c17697037 _d17697037 |
||